This invention provides fully human monoclonal antibodies that recognize IL-17F, the IL- 17F homodimer,IL--17A, the IL- 17A homodimer, and/or the heterodimeric IL- 17A/IL-17Fprotein complex. The invention further provides methodsof using such monoclonal antibodies as a therapeutic, diagnostic, andprophylactic.